2,6-Dimethyl-4-(1,3,4-oxadiazol-2-yl)quinoline

被引：1
|
作者：
Kashaev, Artyom G. [2 ]
Zimichev, Anatoliy V. [2 ]
Rybakov, Victor B. [1 ]
Klimochkin, Yurij N. [2 ]
Zemtsova, Margarita N. [2 ]
机构：
[1] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119992, Russia
[2] Samara State Tech Univ, Samara 443100, Russia
来源：
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2010年 / 66卷
关键词：
D O I：
10.1107/S1600536810048683
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
The title compound, C13H11N3O, a potential chemotherapeutic agent, contains a essential planar [maximum deviation = 0.0144 (14) angstrom] quinoline moiety. The quinoline ring system and the five-membered heterocycle form a dihedral angle of 7.81 (6)degrees. In the crystal, intermolecular non-classical C-H center dot center dot center dot N hydrogen bonding is present.
引用
收藏
页码：O3333 / U2118
页数：9
相关论文
共 50 条
  • [21] SYNTHESIS OF 3-(5-ARYL-1,3,4-OXADIAZOL-2-YL)QUINAZOLINE-2,4-(1H)-DIONES AND 2-[(5-ARYL-1,3,4-OXADIAZOL-2-YL)AMINO]-3,1-BENZOXAZIN-4-ONES FROM METHYL N-(5-ARYL-1,3,4-OXADIAZOL-2-YL)DITHIOCARBAMATES
    KHAN, RH
    RASTOGI, RC
    JOURNAL OF CHEMICAL RESEARCH-S, 1992, (10): : 342 - 343
  • [22] Synthesis and Antibacterial Activity of Novel Series of 2-(p-Tolyloxy)-3-(5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)quinoline
    Joshi, Ratnadeep S.
    Mandhane, Priyanka G.
    Khan, Wajid
    Gill, Charansingh H.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2011, 48 (04) : 872 - 876
  • [23] 1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}butane
    Liu, Qing-lei
    Wang, Wei
    Gao, Yan
    Jia, Xiao-yu
    Zhang, Jing-jing
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O740 - U2858
  • [24] 2-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl acetate
    dos Santos, Alexsandro F.
    Cristiano, Rodrigo
    Athayde-Filho, Petronio F.
    Bortoluzzi, Adailton J.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O559 - +
  • [25] Crystal structures of 3-methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile and N-(4-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide
    Lakshmithendral, K.
    Archana, K.
    Saravanan, K.
    Kabilan, S.
    Selvanayagam, S.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2018, 74 : 1919 - +
  • [26] Tetraaquabis(2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetato)iron(II)
    Wang, Hai-Rong
    Li, Guo-Ting
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : M1457 - U1426
  • [27] Synthesis of 3-(5-aryl-1,3,4-oxadiazol-2-yl)chromones
    Tsao, L
    Van, V
    Sun, G
    Lyu, Y
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2001, 71 (05) : 767 - 769
  • [28] Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors
    Yang, Chaofu
    Feng, Yan
    Yang, Xu
    Sun, Mingxia
    Li, Zhenwang
    Liu, Xuan
    Lu, Liang
    Sun, Xianyu
    Zhang, Jiwen
    He, Xinhua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (02)
  • [29] 4-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-phenylene diacetate
    Vencato, I
    Gallardo, H
    Meyer, E
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1996, 52 : 2301 - 2303
  • [30] Synthesis and antitumor activity of oxazol-2-yl, benzoxazol-2-yl and 1,3,4-oxadiazol-2-yl sulfur ethers
    Zhang, Cheng-Ren
    Wang, Liu
    Ge, Yan-Li
    Ju, Xiu-Lian
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2007, 27 (11) : 1432 - 1437
12345